Itonis, Inc. (ITNS) Research
Itonis, Inc. operates as a development-stage entity, concentrating on the development and distribution of homeopathic remedies, available both over-the-counter and by prescription, aimed at addressing common ailments and chronic conditions. Specifically, the company plans to introduce an over-the-counter preparation targeting mild to moderate nausea, having already commissioned the initial production batch for its Emesyl product line. Established in 2005, Itonis, Inc., which rebranded from Kenshou, Inc. in December of that year, maintains its corporate headquarters in Laguna Hills, California.
Market snapshot
- Symbol
- ITNS
- Price
- $0.00
- Day change
- 0.00%
- Market cap
- $609.4K
- P/E ratio
- -53.70x
- 52-week range
- 0.0002-0.0006
- Sector
- Healthcare
- Industry
- Medical - Distribution
Peer companies
Open Itonis, Inc. (ITNS) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.